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A B S T R A C T
Background: We previously reported that the transmural myocardial strain proﬁle (TMSP) was an
effective predictor for subclinical left ventricular (LV) dysfunction in patients with Duchenne muscular
dystrophy (DMD) with preserved LV ejection fraction (LVEF), but its predictive power when used alone
proved to be limited.
Methods: A total of 95 DMD patients with LVEF of 59  5% (all 55%) and age 11.3  3.0 years were
analyzed retrospectively. Echocardiography was performed at baseline and 1-year follow-up, and all baseline
measurements were repeated during a passive leg-lifting maneuver with legs elevated to approximately 458
from the horizontal position. TMSP of the posterior wall was evaluated from the mid-LV short-axis view. On
the basis of our previous ﬁndings, TMSP with a notch was adopted as a predictor for evaluation of subclinical
LV dysfunction in DMD patients whose LVEF remains preserved.
Results: At baseline, normal TMSP comprised 35 patients (37%), and the remaining 60 (63%) were
classiﬁed as TMSP with a notch. Twenty-nine patients (48%) had developed LV wall motion abnormality
at the 1-year follow-up, but this was observed only in the group of patients with TMSP with a notch at
rest and also during passive leg-lifting. Furthermore, this group showed signiﬁcantly more frequent
development of LV wall motion abnormality at 1-year follow-up, with better sensitivity, speciﬁcity, and
positive and negative predictive values for prediction of this abnormality than for other sub-groups.
Conclusions: Most DMD patients suffer from progressive skeletal muscle weakness, so that combining
TMSP with passive leg-lifting may make TMSP even more effective as a simple and non-invasive
predictor of LV subclinical dysfunction.
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Duchenne muscular dystrophy (DMD) is an X-linked recessive
disease affecting approximately 1 in 3500 live-born male children
worldwide [1]. DMD is caused by mutations in the dystrophin geneDOI of commentary article: http://dx.doi.org/10.1016/j.jjcc.2015.03.013
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0914-5087/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsthat result in marked reduction or absence of the sarcolemmal
protein dystrophin. Death is usually due to cardiac or respiratory
failure [2,3], and distinctive pathologic ﬁndings have been noted
[4]. The incidence of cardiac complications in DMD patients
increases with age, affecting 30% of patients by the age of 14 years,
50% by the age of 18 years, and all older patients [5]. Since
subclinical left ventricular (LV) myocardial dysfunction may
develop and progress early in life, early detection of these changes
in DMD patients, so that medical treatment can be administered
earlier, is vital for prevention of the development of LV myocardial
ﬁbrosis. Previous investigators have reported that myocardial reserved.
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myocardial dysfunction in DMD patients with preserved LV
function [6–11]. In addition, we previously reported that the
transmural myocardial strain proﬁle (TMSP) was effective for
predicting LV dysfunction in such patients [11]. However, these
echocardiographic parameters alone proved to have limited
predictive power for subclinical LV dysfunction. Although exercise
or dobutamine stress echocardiography are well-established
methods for the detection of subclinical LV myocardial dysfunction
in patients with known or suspected cardiomyopathy whose LV
function is normal compared to baseline echocardiographic
assessment [12,13], it is difﬁcult for DMD patients to undergo
such stress tests due to progressive skeletal muscle weakness with
loss of ambulatory ability. On the other hand, the passive leg-lifting
maneuver is a non-invasive and cost-effective method to increase
preload through a transient increase in venous return. The
advantage of this simple maneuver over other stress tests for
DMD patients is that it can be easily performed for such patients
even when they are in poor physical condition with help from an
attendant parent.
Accordingly, the objective of this study was to test the
hypothesis that combining passive leg-lifting with assessment
of TMSP enhances the capability of the latter to predict subclinical
LV dysfunction for DMD patients with preserved LV ejection
fraction (EF).
Materials and methods
Study population
Data for a total of 168 consecutive DMD patients who were
treated at the Division of Pediatrics of Kobe University Hospital
between August 2007 and December 2013 were analyzed retro-
spectively. The diagnosis of DMD was conﬁrmed by genetic analysis.
Mutation of the dystrophin gene, which forces the abnormal
generation of dystrophin messenger RNA by the premature stop
codon, was detected in all patients. We excluded DMD patients with
(1) atrial ﬁbrillation; (2) left-sided heart failure; and (3) more than
mild aortic and/or mitral valvular heart disease. This study was
approved by the local ethics committee of our institution, and
written informed consent was obtained from all patients.Fig. 1. An example of color-coded tissue Doppler radial strain display from the mid-left
color-coded transmural myocardial strain proﬁle of the LV posterior wall (right). (For inte
web version of the article.)Echocardiographic examination
All echocardiographic studies were obtained with a commer-
cially available system (Aplio XG; Toshiba Medical Systems,
Tochigi, Japan) at baseline and 1-year follow-up. All baseline
measurements were repeated during a passive leg-lifting maneu-
ver, in which the legs are elevated to approximately 458 from the
horizontal position with the assistance of attendant parents and
kept at this position for about 1–2 min while continuously
recording echocardiographic data. Digital routine cine loops were
obtained from the standard parasternal and apical views from
three consecutive beats at the end of expiratory apnea. Sector
width was optimized to allow for complete myocardial visualiza-
tion while maximizing the frame rate. Standard LV measurements
were obtained from the parasternal long-axis view, and LV
volumes and EF were calculated using the Teichholz rule
[14]. The pulsed-wave Doppler-derived early diastolic (E) and
atrial transmitral ﬂow velocity (A), the E/A ratio, and the E-wave
deceleration time were obtained from the apical four-chamber
view and used for the assessment of LV diastolic function
[15]. Digital data were transferred to dedicated ofﬂine software
(EchoEgent; Toshiba Medical Systems), for subsequent ofﬂine
strain analysis.
Assessment of TMSP
Tissue Doppler radial strain in the posterior wall was assessed
from the mid-LV short-axis view to obtain TMSP as previously
described in detail [11,16,17]. Brieﬂy, Doppler angle correction was
performed toward the contraction center to obtain radial strain
distribution in the posterior wall. Radial strain distribution
throughout the myocardium in the form of M-mode color-coded
images, as well as the proﬁle of distribution at end-systole, was
also obtained (Fig. 1). Moreover, the location of the peak strain was
identiﬁed, which was determined as the percentage of the distance
between the endocardium and the epicardium accounted for by
the wall thickness (Fig. 1). Two TMSP patterns were observed at
baseline in DMD patients [11] (Fig. 2). One featured a one-peak
strain and was located in the endocardium (normal TMSP), and the
other featured a two-peak strain with a notch and was located in
the subendocardium (TMSP with a notch). Care must be taken to ventricular (LV) short-axis view at end-systole (left), and corresponding M-mode
rpretation of the references to color in this ﬁgure legend, the reader is referred to the
Fig. 2. Examples of two different patterns of transmural myocardial strain proﬁle (TMSP), demonstrating one-peak strain located in the endocardium (left; normal TMSP), and
a two-peak strain with a notch located in the endocardium (right; TMSP with a notch).
Fig. 3. Enrollment of patients in this study. DMD, Duchenne muscular dystrophy;
TMSP, transmural myocardial strain proﬁle; LV, left ventricular.
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for TMSP analysis. On the basis of our previous ﬁndings, TMSP with
a notch was determined as a predictor for subclinical early changes
in DMD patients with preserved LVEF [11]. Acceptable reproduc-
ibility of TMSP was previously established in our laboratory [11].
Statistical analysis
All group data were compared by using the two-tailed Student’s
t test for paired and unpaired data and are presented as mean  SD.
Proportional differences were evaluated by using either Fisher’s exact
test or the x2 test as appropriate. Sensitivity, speciﬁcity, and positive
and negative predictive values were estimated with their 95%
conﬁdence intervals (95% CI). For all steps, p-values <0.05 were
considered statistically signiﬁcant. All the analyses were performed
with commercially available software R version 3.0.2 (R Foundation
for Statistical Computing, Vienna, Austria).
Results
Patient characteristics
After exclusion of three patients (1.8%) with suboptimal images
due to poor-quality echocardiographic windows, 53 (31.5%) due to
LV regional wall motion abnormality, and 17 (10.1%) who refused
to comply with the leg-lifting procedure, the ﬁnal study group
comprised the 95 remaining DMD patients for whom baseline and
1-year follow-up echocardiographic data were available (Fig. 3).
The baseline clinical and echocardiographic characteristics of the
DMD patients are summarized in Table 1. The mean age was
11.3  3.0 years (range 4–23 years), and LVEF was 58.6  5.3% (all
55%).
Baseline comparison of two groups
At baseline, normal TMSP accounted for 35 patients (37%), and
the remaining 60 (63%) were classiﬁed as TMSP with a notch.
Baseline clinical and echocardiographic characteristics of the two
groups are listed in Table 1. The two groups showed similar
baseline clinical and echocardiographic characteristics, except for
E-deceleration time for patients with TMSP with a notch, which
was signiﬁcantly longer (169.6  28.7 ms vs. 151.1  22.5 ms;
p < 0.01), and peak strain, which was signiﬁcantly lower
(216.9  96.8% vs. 137. 3  64.0%; p < 0.01).Response to passive leg-lifting
Passive leg-lifting resulted in a signiﬁcant increase in LV end-
diastolic and left atrial diameter, LVEF, and peak strain value, and a
decrease in LV posterior wall thickness (Table 2). In addition,
response to passive leg-lifting was similar for patients with normal
TMSP and TMSP with a notch. Of the 35 patients with normal TMSP
at rest, TMSP with a notch as a result of leg-lifting emerged in
10 patients, but not in the remaining 25. Similarly, of the
60 patients with TMSP with a notch, this condition persisted in
49 patients as a result of leg-lifting, but it disappeared in the
remaining 11 patients (Fig. 4).
Prediction of LV wall motion abnormality in the posterior wall at 1-
year follow-up
At the 1-year follow-up, 29 patients (48%) had developed LV
wall motion abnormality in the posterior wall, which was observed
in only patients with TMSP with a notch at rest, but not in those
with normal TMSP at rest (Fig. 4). Interestingly, of the 60 patients
with TMSP with a notch, 29 who had developed wall motion
abnormality in the posterior wall at the 1-year follow-up showed
persisting TMSP with a notch as a result of passive leg-lifting, but
Table 1
Baseline clinical and echocardiographic characteristics of patients.
Variables All patients (n = 95) Normal TMSP (n = 35) TMSP with a notch (n = 60) p-Value
Age (years) 11.3  3.0 10.9  2.7 11.6  3.1 0.31
Systolic BP (mmHg) 106  10 106  9 105  11 0.65
Diastolic BP (mmHg) 63  7 63  7 63  7 0.96
Heart rate (bpm) 92  12 90  13 94  11 0.17
Creatine kinase (IU/l) 5377  4538 5792  3847 5134  4916 0.50
Aldolase (IU/l) 38  29 39  21 38  34 0.81
BNP (pg/ml) 9.9  7.8 8.9  5.7 10.5  8.8 0.34
Echocardiographic parameters
LVDd (mm) 39.7  4.2 39.6  4.5 39.8  4.1 0.85
LVDs (mm) 25.9  3.6 25.6  3.8 26.1  3.6 0.58
LVEF (%) 58.6  5.3 59.5  5.1 58.4  5.5 0.31
LAD (mm) 23.1  4.8 23.9  3.2 22.6  5.4 0.16
IVST (mm) 7.3  1.3 7.4  1.3 7.2  1.3 0.40
LVPWT (mm) 7.5  1.5 7.9  1.4 7.3  1.5 0.06
E (cm/s) 96.3  16.1 98.0  14.1 95.3  17.3 0.43
A (cm/s) 45.9  12.5 46.2  11.5 45.7  13.2 0.82
E/A ratio 2.24  0.70 2.2  0.6 2.2  0.8 0.96
E-DcT (ms) 162.4  27.9 151.1  22.5 169.6  28.7 <0.01
Peak strain (%) 166.6  86.3 216.9  96.8 137. 3  64.0 <0.01
TMSP, transmural strain proﬁle; BP, blood pressure; BNP, brain natriuretic peptide; LVDd, left ventricular end-diastolic dimension; LVDs, left ventricular end-systolic
dimension; LVEF, left ventricular ejection fraction; LAD, left atrial dimension; IVST, intra-ventricular septal thickness; LVPWT, left ventricular posterior wall thickness; E,
early diastolic wave velocity; A, atrial wave velocity; E/A, early diastolic and atrial wave velocities ratio; E-DcT, early diastolic-wave deceleration time.
Table 2
Response to passive leg-lifting.
All patients (n = 95) Normal TMSP (n = 35) TMSP with a notch (n = 60)
Rest Leg-lifting p-Value Rest Leg-lifting p-Value Rest Leg-lifting p-Value
Heart rate (bpm) 92  12 91  13 0.15 90  13 90  12 0.37 94  12 92  14 0.12
Echocardiographic parameters
LVDd (mm) 39.7  4.2 41.2  4.4 <0.01 39.6  4.5 41.3  4.7 <0.01 39.8  4.1 41.1  4.2 <0.01
LVDs (mm) 25.9  3.6 26.2  3.9 0.18 25.6  3.8 26.1  4.1 0.33 26.1  3.6 26.4  3.8 0.38
LVEF (%) 58.6  5.3 60.4  6.3 <0.01 59.5  5.1 61.2  6.8 0.03 58.4  5.5 60.0  6.0 0.03
LAD (mm) 23.1  4.8 25.3  4.7 <0.01 23.9  3.2 25.9  3 <0.01 22.6  5.4 24.8  5.4 <0.01
IVST (mm) 7.3  1.3 7.4  1.1 0.50 7.4  1.3 7.5  1.3 0.89 7.2  1.3 7.3  1.0 0.46
LVPWT (mm) 7.5  1.5 6.8  1.2 <0.01 7.9  1.4 6.8  1.1 <0.01 7.3  1.5 6.8  1.3 <0.01
Peak strain (%) 167  86 193  113 <0.01 217  97 255  132 0.02 137  64 157  82 0.04
TMSP, transmural strain proﬁle; LVDd, left ventricular end-diastolic dimension; LVDs, left ventricular end-systolic dimension; LVEF, left ventricular ejection fraction;
LAD, left atrial dimension; IVST, intra-ventricular septal thickness; LVPWT, left ventricular posterior wall thickness.
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showed it (Fig. 4). In addition, patients with persisting TMSP with a
notch following passive leg-lifting showed a signiﬁcantly higher
prevalence of the development of LV wall motion abnormality inFig. 4. Prevalence of the development of left ventricular (LV) wall motion
abnormality in the posterior wall at 1-year follow-up, demonstrating that patients
with persisting transmural myocardial strain proﬁle (TMSP) with a notch as a result
of leg-lifting showed a signiﬁcantly higher prevalence of development of LV wall
motion abnormality than other sub-groups.the posterior wall at 1-year follow-up, and better sensitivity,
speciﬁcity, and positive and negative predictive values for
prediction of this abnormality than other sub-groups (Fig. 4 and
Table 3). Fig. 5 shows a representative case in a patient with the
development of LV wall motion abnormality in the posterior wall
at 1-year follow-up.
Discussion
The ﬁndings of our study demonstrate that combining the
passive leg-lifting maneuver with assessment of TMSP may be
more effective for predicting new development of LV posterior wall
motion abnormality after 1 year for DMD patients with preserved
LVEF. These ﬁndings may further enhance our previously reported
capability of TMSP assessment to predict subclinical LV dysfunc-
tion.
Importance of early detection of cardiac involvement in DMD patients
Death of DMD patients is usually due to cardiac or respiratory
failure [2,3], and distinctive pathologic ﬁndings for these patients
have been noted [4]. The incidence of cardiac complications in
DMD patients increases with age, affecting 30% of patients by the
age of 14 years, 50% by the age of 18, and all older patients
[5]. Overt symptoms due to heart failure resulting from severe
limitations of daily activities occur in about 30% of cases [18]. Since
Table 3
Prediction of LV wall motion abnormality in the posterior wall at 1-year follow-up.
Sensitivity (%) (95% CI) Speciﬁcity (%) (95% CI) PPV (%) (95% CI) NPV (%) (95% CI)
Normal TMSP at rest (n = 35) 0 (0–0.172) 47.0 (0.346–0.597) 0 (0–0.145) 51.7 (0.384–0.648)
Passive leg-lifting
Persisting normal TMSP (n = 25) 0 (0–0.172) 62.1 (0.493–0.738) 0 (0–0.196) 58.6 (0.462–0.702)
Appearance of TMSP with a notch (n = 10) 0 (0, 0.172) 62.1 (0.493–0.738) 0 (0–0.196) 58.6 (0.462–0.702)
TMSP with a notch at rest (n = 60) 100 (0.828–1) 53.0 (0.403–0.654) 48.3 (0.352–0.616) 100 (0.855–1)
Passive leg-lifting
Persisting TMSP with a notch (n = 49) 100 (0.828–1) 69.7 (0.571, 0.804) 59.2 (0.442–0.73) 100 (0.887–1)
Disappearance of TMSP with a notch (n = 11) 0 (0–0.172) 83.3 (0.721–0.914) 0 (0–0.385) 65.5 (0.543–0.755)
LV, left ventricular; CI, conﬁdence interval; PPV, positive predictive values; NPV, negative predictive values; TMSP, transmural strain proﬁle.
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early in life, the early detection of this abnormality in DMD
patients when their LVEF remains preserved is important because
medical treatment can be administered earlier, and is therefore
vital for prevention of the development of myocardial ﬁbrosis
[19,20]. Fibrotic changes, however, do not always occur homo-
geneously in the heart and cardiac ﬁbrosis in DMD patients begins
in the outer half of the myocardium, especially in the LV posterior
wall [21,22]. Moreover, early detection of subclinical LV dysfunc-
tion in DMD patients with preserved LVEF can be challenging [23].
We previously reported in a study of 82 DMD patients with
preserved LVEF that TMSP with a notch at rest functioned as a
robust predictor of the presence of LV posterior wall motion
abnormality detected at 1-year follow-up rather than simple strain
values [11]. Since TMSP with a notch may link to regional
myocardial thinning in systole (negative strain value which is just
above the notch in Fig. 2), it may be associated with subtle LV
ﬁbrosis, which can be an accurate parameter of LV myocardial
function. In addition, we speculated that TMSP with notch was alsoFig. 5. A representative case in a 13-year-old boy with the development of left ventricular
echocardiography shows 58% of LV ejection fraction (LVEF) without LV wall motion abno
baseline (arrow), and this condition persisted as a result of passive leg-lifting (arrow)
abnormality in the posterior wall. LVDd, left ventricular end-diastolic diameter; LVDs,associated with the changes in the myoﬁbrillar properties of the
myocardial cells and disappearance of the transmural gradient of
myoﬁlament length-dependent activation. However, the predic-
tive power of this method alone was limited by a relatively low
speciﬁcity and positive predictive value as a predictor. Exercise
stress echocardiography involving bicycle and treadmill exercise
testing or low-dose dobutamine stress echocardiography are well-
established methods for the detection of subclinical LV myocardial
dysfunction in patients with known or suspected cardiomyopathy
whose LV function is normal. In addition, passive leg-lifting is a
non-invasive and cost-effective method to increase preload
through a transient increase in venous return and therefore has
several advantages over the above-mentioned stress test for the
assessment of subclinical LV dysfunction in DMD patients, because
it does not signiﬁcantly affect blood pressure, heart rate, or
afterload, and its effect lasts only a short time. This is important
because most DMD patients are not capable of performing such
stress testing due to their poor physical condition including
progressive skeletal muscle weakness with loss of ambulatory (LV) wall motion abnormality in the posterior wall at 1-year follow-up. (A) Baseline
rmality. The patient had transmural myocardial strain proﬁle (TMSP) with a notch at
. (B) 1-Year follow-up echocardiography shows 36% of LVEF with LV wall motion
 left ventricular end-systolic diameter.
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preload is a simple and suitable stress test, and it is recommended
here as an alternative substitute test for the more conventional
non-invasive method, because it can be easily performed by DMD
patients during echocardiography with the help from an attendant
parent. Therefore, the combination of the passive leg-lifting
maneuver with assessment of TMSP can be expected to constitute
a more effective predictor of subclinical LV dysfunction in DMD
patients. Moreover, these ﬁndings appear to highlight the
importance of early medical treatment to prevent the development
of LV myocardial ﬁbrosis for the risk stratiﬁcation in DMD patients.
It would be considered that the increased preload by means of
passive leg-lifting results in an increased peak strain value without
the change of strain distribution in the normal segments because of
Frank–Starling mechanism. On the other hand, such a phenome-
non may not occur in the segments with subclinical myocardial
dysfunction, and the persisting TMSP with a notch by passive leg-
lifting may well reﬂect the presence of subclinical myocardial
dysfunction. In this study, 10 patients with normal TMSP appeared
TMSP with a notch by passive leg-lifting, and these patients did not
develop LV wall motion abnormality in the posterior wall at 1-year
follow-up. Although this phenomenon seems to be not a bad sign,
the precise mechanism remains uncertain. A larger study
population with longer follow-up period would be needed to
validate this ﬁnding.
Study limitations
There are certain limitations to this study. First, this study
covered a small number of patients in a single-center retrospective
study, so that future studies of larger patient populations are
necessary to assess our ﬁndings. Only radial strain in the LV
posterior wall from the mid-LV short-axis view was assessed, and
assessments of other directional strains or other LV segments were
not a part of this study. Thus, the assessment of TMSP in the whole
heart would be a better parameter than that of regional TMSP.
Although it remains to be completely elucidated, the LV posterior
wall is the preferred site for wall motion abnormalities in DMD
patients. Second, the reproducibility of passive leg-lifting maneu-
ver in DMD patients was not part of this study. Third, vital signs
except heart rate were not collected during the passive leg-lifting
maneuver. Finally, the passive leg-lifting maneuver may have
shortcomings as a quantitative parameter, but in our study LV end-
diastolic and left atrial diameter and LVEF signiﬁcantly increased,
while LV end-systolic diameter as well as heart rate remained
unchanged in response to passive leg-lifting. We therefore believe
that our ﬁndings conﬁrmed the clinical utility of the passive leg-
lifting maneuver as a means of increasing preload without altering
afterload.
Conclusions
The combination of TMSP and passive leg-lifting maneuver may
be even more effective than the former alone as a simple and non-
invasive predictor of LV subclinical dysfunction. The ﬁndings
presented here are thus expected to have clinical implications for
better management of such patients.
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